Active Pharmaceutical Ingredients (APIs)
PRESENCE OF ORGANIC IMPURITIES INTO ACTIVE PHARMACEUTICAL INGREDIENTS: A REVIEW
31
Crystal Engineering of Active Pharmaceutical Ingredients with Low Aqueous Solubility and Bioavailability
130
“GC and GC-MS Detection of Alkyl Mesylates in Active Pharmaceutical Ingredients” by N Balaji, Sayeeda Sultana, India.
5
POLYMORPHISM AND SOLUBILITY OF SELECTED ACTIVE PHARMACEUTICAL INGREDIENTS
15
Self-assembled sorbitol-derived supramolecular hydrogels for the controlled encapsulation and release of active pharmaceutical ingredients
6
Regulatory Aspects of Cleaning and Cleaning Validation in Active Pharmaceutical Ingredients
6
ELECTROSPRAY IONIZATION MASS SPECTROMETRY FRAGMENTATION PATHWAYS OF SALTS OF SOME 1,2,4 TRIAZOLYLTHIOACETATE ACIDS, THE ACTIVE PHARMACEUTICAL INGREDIENTS
10
Sustainable Production of Highly Active Pharmaceutical Ingredients (HAPIs)
5
Study of technological properties of the active pharmaceutical ingredients for developing the combined medicine for neuropathy complex treatment
5
Co-crystals: A novel approach to modify physicochemical properties of active pharmaceutical ingredients
12
Development and application of high resolution solid state NMR methods for probing polymorphism of active pharmaceutical ingredients
170
Assessment of active pharmaceutical ingredients in drug registration procedures in Pakistan : implications for the future
14
SULFONIC ACID COUNTER IONS QUANTIFICATION IN PHARMACEUTICALS BY ION CHROMATOGRAPHY
8
The production and sales of anti-tuberculosis drugs in China
6
Enabling precision manufacturing of active pharmaceutical ingredients : workflow for seeded cooling continuous crystallisation
32
Investigating effect of water of hydration on active pharmaceutical ingredients in a water-sensitive dosage form
8
A NOVEL VALIDATED STABILITY INDICATING HPTLC METHOD FOR THE SIMULTANEOUS ESTIMATION OF IRBESARTAN AND HYDROCHLOROTHIAZIDE IN ACTIVE PHARMACEUTICAL INGREDIENTS
14
Enabling precision manufacturing of active pharmaceutical ingredients : workflow for seeded cooling continuous crystallisations
32
Mind the gaps the epidemiology of poor quality anti malarials in the malarious world analysis of the WorldWide Antimalarial Resistance Network database
14
A NOVEL RP HPLC METHOD FOR THE QUANTIFICATION OF CABOZANTINIB IN ACTIVE PHARMACEUTICAL INGREDIENTS AND PHARMACEUTICAL DOSAGE FORMS
7